Cyrus Taraporevala serves as the President and Chief Executive Officer at Pfizer Inc. in 2024. In this role, he leads the global pharmaceutical giant, overseeing its strategic direction and operational execution. Taraporevala is not an independent board member, reflecting his executive position within the company. He is a member of the Audit Committee, bringing his expertise in finance and accounting to bear on the company's financial oversight and governance.

Before joining Pfizer, Taraporevala had a distinguished career in the financial services industry. He previously served as the President and CEO of State Street Global Advisors, one of the world's largest institutional asset managers. During his tenure, he successfully navigated the company through the challenging financial landscape, driving growth and innovation. His leadership at State Street Global Advisors earned him a reputation as a strategic thinker and effective executive.

At Pfizer, Taraporevala's responsibilities extend beyond his role on the Audit Committee. He is also involved in the company's broader business leadership and operations, applying his extensive experience in international business to guide Pfizer's global strategy. Additionally, his background in risk management and human capital management contributes to his effectiveness as a leader, ensuring that Pfizer remains at the forefront of the pharmaceutical industry. Under his leadership, Pfizer continues to focus on developing innovative treatments and vaccines, building on its legacy of improving global health outcomes.